Patents by Inventor Graeme Walter McRobbie

Graeme Walter McRobbie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION
    Publication number: 20230022430
    Abstract: The present invention provides a cassette for determining optimised solid phase extraction (SPE) purification conditions, wherein said cassette comprises: (i) a flowpath comprising a first end and a second end; and (ii) a plurality of valves oriented along said flowpath, wherein each of said plurality of valves is selectively fluidly connected to one of a number of components, wherein said components comprise: (a) 1-5 composition vials; (b) 1-3 SPE cartridges; (c) 4-10 solvent vials; (d) a water vial; and (e) a transfer line.
    Type: Application
    Filed: December 17, 2020
    Publication date: January 26, 2023
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Graeme Walter MCROBBIE, Imtiaz Ahmed Khan, Jonathan Robert SHALES
  • APOPTOSIS PET IMAGING AGENTS
    Publication number: 20130251632
    Abstract: The present invention relates to radiopharmaceutical imaging in vivo of apoptosis and other forms of cell death. The invention provides PET imaging agents which target apoptotic cells via selective binding to the aminophospholipid phosphatidylethanolamine (PE), which is exposed on the surface of apoptotic cells. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.
    Type: Application
    Filed: December 1, 2011
    Publication date: September 26, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Duncan Hiscock, Bente Elizabeth Arbo, Graeme Walter Mcrobbie, Bard Indrevoll, Rajiv Bhalla
  • APOPTOSIS IMAGING AGENTS BASED ON LANTIBIOTIC PEPTIDES
    Publication number: 20130189186
    Abstract: The present invention relates to radiopharmaceutical imaging in vivo of apoptosis. The invention provides imaging agents which target apoptotic cells via selective binding to the aminophospholipid phosphatidylethanolamine (PE), which is exposed on the surface of apoptotic cells. The radiopharmaceuticals comprise radiometal complexes of chelator conjugates of PE-binding peptides. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.
    Type: Application
    Filed: September 27, 2011
    Publication date: July 25, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Bard Indrevoll, Duncan Hiscock, Bente Elizabeth Arbo, Rajiv Bhalla, Matthias Eberhard Glaser, Graeme Walter McRobbie